Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Prüfung der Ergänzung der Pillen-Chemotherapie Cabozantinib zur Standard-Immuntherapie Nivolumab im Vergleich zur Standard-Chemotherapie bei nicht-kleinzelligem Lungenkrebs

11. November 2026 aktualisiert von: National Cancer Institute (NCI)

Eine randomisierte Phase-II-Studie mit Cabozantinib und Cabozantinib plus Nivolumab im Vergleich zu einer Standard-Chemotherapie bei Patienten mit vorbehandeltem NSCLC ohne Plattenepithelkarzinom

This phase II trial compares cabozantinib alone and the combination of cabozantinib and nivolumab to standard chemotherapy in the treatment of patients with non-squamous non-small cell lung cancer (NSCLC). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as docetaxel, gemcitabine hydrochloride, paclitaxel, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving cabozantinib alone or in combination with nivolumab may be more effective than standard chemotherapy in treating patients with non-small cell lung cancer.

Studienübersicht

Detaillierte Beschreibung

PRIMARY OBJECTIVE:

I. To determine whether cabozantinib alone, or the combination of nivolumab and cabozantinib, as compared to standard chemotherapy alone, extends progression-free survival (PFS) for this patient population with non squamous NSCLC.

SECONDARY OBJECTIVES:

I. To determine the overall survival for each arm of the trial. II. To evaluate the best overall radiographic response rate for each arm of the trial.

III. To evaluate and describe the toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib in this patient population with non-squamous NSCLC.

EXPLORATORY IMAGING OBJECTIVES:

I. To describe time point tumor response assessment, overall best response, progression-free survival and overall survival using the conventional Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria and the exploratory revised CHOI criteria with all measurements performed by the central review.

II. To compare the progression-free survival using the RECIST1.1 imaging response assessment measurements by site study personnel to those performed by central review.

EXPLORATORY CORRELATIVE OBJECTIVE:

I. To perform correlative biomarker research on tissue and blood biospecimens collected within this trial.

OUTLINE:

STEP 1: Patients are randomized to 1 of 3 arms.

ARM A: Patients receive cabozantinib S-malate orally (PO) once daily (QD). Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.

ARM B: Patients receive cabozantinib S-malate PO QD and nivolumab intravenously (IV) over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.

ARM C: Patients receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician.

STEP 2: Patients in Arm C experiencing disease progression are assigned to Arm Z.

ARM Z: Patients receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit.

Patients in all arms undergo echocardiogram (ECHO) as clinically indicated, computed tomography (CT) throughout the trial, and collection of blood on study.

After the completion of study treatment, patients are followed up every 3 months for up to 3 years.

Studientyp

Interventionell

Einschreibung (Geschätzt)

117

Phase

  • Phase 2

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Alabama
      • Birmingham, Alabama, Vereinigte Staaten, 35233
        • Veterans Administration Medical Center - Birmingham
    • Alaska
      • Anchorage, Alaska, Vereinigte Staaten, 98508
        • Anchorage Associates in Radiation Medicine
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Alaska Breast Care and Surgery LLC
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Alaska Oncology and Hematology LLC
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Alaska Women's Cancer Care
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Anchorage Oncology Centre
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Katmai Oncology Group
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Providence Alaska Medical Center
      • Anchorage, Alaska, Vereinigte Staaten, 99504
        • Anchorage Radiation Therapy Center
      • Fairbanks, Alaska, Vereinigte Staaten, 99701
        • Fairbanks Memorial Hospital
    • Arizona
      • Goodyear, Arizona, Vereinigte Staaten, 85338
        • CTCA at Western Regional Medical Center
      • Kingman, Arizona, Vereinigte Staaten, 86401
        • Kingman Regional Medical Center
      • Phoenix, Arizona, Vereinigte Staaten, 85004
        • Cancer Center at Saint Joseph's
      • Tucson, Arizona, Vereinigte Staaten, 85719
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, Vereinigte Staaten, 85719
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Fort Smith, Arkansas, Vereinigte Staaten, 72903
        • Mercy Hospital Fort Smith
      • Hot Springs, Arkansas, Vereinigte Staaten, 71913
        • CHI Saint Vincent Cancer Center Hot Springs
    • California
      • Arroyo Grande, California, Vereinigte Staaten, 93420
        • PCR Oncology
      • Arroyo Grande, California, Vereinigte Staaten, 93420
        • Mission Hope Medical Oncology - Arroyo Grande
      • Burbank, California, Vereinigte Staaten, 91505
        • Providence Saint Joseph Medical Center/Disney Family Cancer Center
      • Carmichael, California, Vereinigte Staaten, 95608
        • Mercy San Juan Medical Center
      • Carmichael, California, Vereinigte Staaten, 95608
        • Mercy Cancer Center - Carmichael
      • Elk Grove, California, Vereinigte Staaten, 95758
        • Mercy Cancer Center - Elk Grove
      • Fremont, California, Vereinigte Staaten, 94538
        • Washington Health
      • Marysville, California, Vereinigte Staaten, 95901
        • Fremont - Rideout Cancer Center
      • Orange, California, Vereinigte Staaten, 92868
        • Saint Joseph Hospital - Orange
      • Palo Alto, California, Vereinigte Staaten, 94304
        • Stanford Cancer Institute Palo Alto
      • Rocklin, California, Vereinigte Staaten, 95765
        • Mercy Cancer Center - Rocklin
      • Sacramento, California, Vereinigte Staaten, 95817
        • University of California Davis Comprehensive Cancer Center
      • Sacramento, California, Vereinigte Staaten, 95816
        • Mercy Cancer Center - Sacramento
      • San Luis Obispo, California, Vereinigte Staaten, 93401
        • Pacific Central Coast Health Center-San Luis Obispo
      • Santa Maria, California, Vereinigte Staaten, 93444
        • Mission Hope Medical Oncology - Santa Maria
      • Woodland, California, Vereinigte Staaten, 95695
        • Woodland Memorial Hospital
    • Colorado
      • Aurora, Colorado, Vereinigte Staaten, 80012
        • Rocky Mountain Cancer Centers-Aurora
      • Aurora, Colorado, Vereinigte Staaten, 80012
        • The Medical Center of Aurora
      • Boulder, Colorado, Vereinigte Staaten, 80303
        • Boulder Community Foothills Hospital
      • Boulder, Colorado, Vereinigte Staaten, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Centennial, Colorado, Vereinigte Staaten, 80112
        • Rocky Mountain Cancer Centers - Centennial
      • Colorado Springs, Colorado, Vereinigte Staaten, 80907
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, Vereinigte Staaten, 80907
        • Rocky Mountain Cancer Centers-Penrose
      • Colorado Springs, Colorado, Vereinigte Staaten, 80923
        • Saint Francis Cancer Center
      • Denver, Colorado, Vereinigte Staaten, 80218
        • Presbyterian - Saint Lukes Medical Center - Health One
      • Denver, Colorado, Vereinigte Staaten, 80220
        • Rose Medical Center
      • Denver, Colorado, Vereinigte Staaten, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, Vereinigte Staaten, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, Vereinigte Staaten, 80218
        • Colorado Blood Cancer Institute
      • Denver, Colorado, Vereinigte Staaten, 80204
        • Cancer Center of Colorado at Sloan's Lake
      • Denver, Colorado, Vereinigte Staaten, 80209
        • The Women's Imaging Center
      • Denver, Colorado, Vereinigte Staaten, 80206
        • National Jewish Health-Main Campus
      • Denver, Colorado, Vereinigte Staaten, 80220
        • Western Surgical Care
      • Denver, Colorado, Vereinigte Staaten, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, Vereinigte Staaten, 80210
        • AdventHealth Porter
      • Durango, Colorado, Vereinigte Staaten, 81301
        • Mercy Medical Center
      • Durango, Colorado, Vereinigte Staaten, 81301
        • CommonSpirit Cancer Center Mercy
      • Englewood, Colorado, Vereinigte Staaten, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, Vereinigte Staaten, 80113
        • Swedish Medical Center
      • Englewood, Colorado, Vereinigte Staaten, 80113
        • Rocky Mountain Cancer Centers - Swedish
      • Englewood, Colorado, Vereinigte Staaten, 80113
        • The Melanoma and Skin Cancer Institute
      • Fort Collins, Colorado, Vereinigte Staaten, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, Vereinigte Staaten, 80528
        • Cancer Care and Hematology-Fort Collins
      • Golden, Colorado, Vereinigte Staaten, 80401
        • National Jewish Health-Western Hematology Oncology
      • Grand Junction, Colorado, Vereinigte Staaten, 81501
        • Saint Mary's Hospital and Regional Medical Center
      • Greeley, Colorado, Vereinigte Staaten, 80631
        • UCHealth Greeley Hospital
      • Greeley, Colorado, Vereinigte Staaten, 80631
        • Banner North Colorado Medical Center
      • Highlands Ranch, Colorado, Vereinigte Staaten, 80129
        • UCHealth Highlands Ranch Hospital
      • Lafayette, Colorado, Vereinigte Staaten, 80026
        • Good Samaritan Hospital - Cancer Centers of Colorado
      • Lakewood, Colorado, Vereinigte Staaten, 80228
        • Rocky Mountain Cancer Centers-Lakewood
      • Lakewood, Colorado, Vereinigte Staaten, 80228
        • CommonSpirit Saint Anthony Hospital Cancer Center
      • Littleton, Colorado, Vereinigte Staaten, 80120
        • Rocky Mountain Cancer Centers-Littleton
      • Littleton, Colorado, Vereinigte Staaten, 80122
        • AdventHealth Littleton
      • Lone Tree, Colorado, Vereinigte Staaten, 80124
        • Sky Ridge Medical Center
      • Lone Tree, Colorado, Vereinigte Staaten, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Longmont, Colorado, Vereinigte Staaten, 80501
        • Longmont United Hospital
      • Longmont, Colorado, Vereinigte Staaten, 80501
        • Rocky Mountain Cancer Centers-Longmont
      • Loveland, Colorado, Vereinigte Staaten, 80538
        • Medical Center of the Rockies
      • Loveland, Colorado, Vereinigte Staaten, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Parker, Colorado, Vereinigte Staaten, 80138
        • AdventHealth Parker
      • Pueblo, Colorado, Vereinigte Staaten, 81004
        • Saint Mary Corwin Medical Center
      • Thornton, Colorado, Vereinigte Staaten, 80260
        • Rocky Mountain Cancer Centers-Thornton
      • Thornton, Colorado, Vereinigte Staaten, 80260
        • National Jewish Health-Northern Hematology Oncology
    • Connecticut
      • West Haven, Connecticut, Vereinigte Staaten, 06516
        • Veterans Affairs Connecticut Healthcare System-West Haven Campus
    • Florida
      • Aventura, Florida, Vereinigte Staaten, 33180
        • Mount Sinai Comprehensive Cancer Center at Aventura
      • Fort Lauderdale, Florida, Vereinigte Staaten, 33308
        • Holy Cross Hospital
      • Miami Beach, Florida, Vereinigte Staaten, 33140
        • Mount Sinai Medical Center
    • Georgia
      • Atlanta, Georgia, Vereinigte Staaten, 30308
        • Emory University Hospital Midtown
      • Atlanta, Georgia, Vereinigte Staaten, 30322
        • Emory University Hospital/Winship Cancer Institute
      • Savannah, Georgia, Vereinigte Staaten, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
    • Idaho
      • Boise, Idaho, Vereinigte Staaten, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, Vereinigte Staaten, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Vereinigte Staaten, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Coeur d'Alene, Idaho, Vereinigte Staaten, 83814
        • Kootenai Health - Coeur d'Alene
      • Emmett, Idaho, Vereinigte Staaten, 83617
        • Walter Knox Memorial Hospital
      • Fruitland, Idaho, Vereinigte Staaten, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Vereinigte Staaten, 83642
        • Idaho Urologic Institute-Meridian
      • Meridian, Idaho, Vereinigte Staaten, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Vereinigte Staaten, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, Vereinigte Staaten, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls, Idaho, Vereinigte Staaten, 83854
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint, Idaho, Vereinigte Staaten, 83864
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls, Idaho, Vereinigte Staaten, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Alton, Illinois, Vereinigte Staaten, 62002
        • OSF Saint Anthony's Health Center
      • Aurora, Illinois, Vereinigte Staaten, 60504
        • Rush-Copley Medical Center
      • Barrington, Illinois, Vereinigte Staaten, 60010
        • Advocate Good Shepherd Hospital
      • Bloomington, Illinois, Vereinigte Staaten, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Vereinigte Staaten, 61520
        • Illinois CancerCare-Canton
      • Carbondale, Illinois, Vereinigte Staaten, 62902
        • Memorial Hospital of Carbondale
      • Carterville, Illinois, Vereinigte Staaten, 62918
        • SIH Cancer Institute
      • Carthage, Illinois, Vereinigte Staaten, 62321
        • Illinois CancerCare-Carthage
      • Centralia, Illinois, Vereinigte Staaten, 62801
        • Centralia Oncology Clinic
      • Centralia, Illinois, Vereinigte Staaten, 62801
        • Saint Mary's Hospital
      • Chicago, Illinois, Vereinigte Staaten, 60612
        • University of Illinois
      • Chicago, Illinois, Vereinigte Staaten, 60657
        • Advocate Illinois Masonic Medical Center
      • Crystal Lake, Illinois, Vereinigte Staaten, 60014
        • AMG Crystal Lake - Oncology
      • Danville, Illinois, Vereinigte Staaten, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Vereinigte Staaten, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Vereinigte Staaten, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Dixon, Illinois, Vereinigte Staaten, 61021
        • Illinois CancerCare-Dixon
      • Downers Grove, Illinois, Vereinigte Staaten, 60515
        • Advocate Good Samaritan Hospital
      • Effingham, Illinois, Vereinigte Staaten, 62401
        • Crossroads Cancer Center
      • Effingham, Illinois, Vereinigte Staaten, 62401
        • Carle Physician Group-Effingham
      • Elgin, Illinois, Vereinigte Staaten, 60123
        • Advocate Sherman Hospital
      • Eureka, Illinois, Vereinigte Staaten, 61530
        • Illinois CancerCare-Eureka
      • Galesburg, Illinois, Vereinigte Staaten, 61401
        • Western Illinois Cancer Treatment Center
      • Galesburg, Illinois, Vereinigte Staaten, 61401
        • Illinois CancerCare-Galesburg
      • Hazel Crest, Illinois, Vereinigte Staaten, 60429
        • Advocate South Suburban Hospital
      • Hines, Illinois, Vereinigte Staaten, 60141
        • Edward Hines Jr VA Hospital
      • Kewanee, Illinois, Vereinigte Staaten, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Libertyville, Illinois, Vereinigte Staaten, 60048
        • Condell Memorial Hospital
      • Libertyville, Illinois, Vereinigte Staaten, 60048
        • AMG Libertyville - Oncology
      • Macomb, Illinois, Vereinigte Staaten, 61455
        • Illinois CancerCare-Macomb
      • Mattoon, Illinois, Vereinigte Staaten, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Mount Vernon, Illinois, Vereinigte Staaten, 62864
        • SSM Health Good Samaritan
      • O'Fallon, Illinois, Vereinigte Staaten, 62269
        • Cancer Care Center of O'Fallon
      • Oak Lawn, Illinois, Vereinigte Staaten, 60453-2699
        • Advocate Christ Medical Center
      • Ottawa, Illinois, Vereinigte Staaten, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Park Ridge, Illinois, Vereinigte Staaten, 60068
        • Advocate Lutheran General Hospital
      • Pekin, Illinois, Vereinigte Staaten, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Vereinigte Staaten, 61636
        • Methodist Medical Center of Illinois
      • Peoria, Illinois, Vereinigte Staaten, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Vereinigte Staaten, 61354
        • Illinois CancerCare-Peru
      • Peru, Illinois, Vereinigte Staaten, 61354
        • Valley Radiation Oncology
      • Princeton, Illinois, Vereinigte Staaten, 61356
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, Vereinigte Staaten, 61114
        • UW Health Carbone Cancer Center Rockford
      • Springfield, Illinois, Vereinigte Staaten, 62702
        • Southern Illinois University School of Medicine
      • Springfield, Illinois, Vereinigte Staaten, 62702
        • Springfield Clinic
      • Springfield, Illinois, Vereinigte Staaten, 62781
        • Springfield Memorial Hospital
      • Swansea, Illinois, Vereinigte Staaten, 62226
        • Southwest Illinois Health Services LLP
      • Urbana, Illinois, Vereinigte Staaten, 61801
        • Carle Cancer Center
      • Urbana, Illinois, Vereinigte Staaten, 61801
        • The Carle Foundation Hospital
      • Washington, Illinois, Vereinigte Staaten, 61571
        • Illinois CancerCare - Washington
      • Yorkville, Illinois, Vereinigte Staaten, 60560
        • Rush-Copley Healthcare Center
    • Indiana
      • Richmond, Indiana, Vereinigte Staaten, 47374
        • Reid Health
      • South Bend, Indiana, Vereinigte Staaten, 46601
        • Memorial Hospital of South Bend
    • Iowa
      • Ames, Iowa, Vereinigte Staaten, 50010
        • Mary Greeley Medical Center
      • Ames, Iowa, Vereinigte Staaten, 50010
        • McFarland Clinic - Ames
      • Bettendorf, Iowa, Vereinigte Staaten, 52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Boone, Iowa, Vereinigte Staaten, 50036
        • McFarland Clinic - Boone
      • Carroll, Iowa, Vereinigte Staaten, 51401
        • Saint Anthony Regional Hospital
      • Clive, Iowa, Vereinigte Staaten, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, Vereinigte Staaten, 50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Council Bluffs, Iowa, Vereinigte Staaten, 51503
        • Alegent Health Mercy Hospital
      • Council Bluffs, Iowa, Vereinigte Staaten, 51503
        • Heartland Oncology and Hematology LLP
      • Council Bluffs, Iowa, Vereinigte Staaten, 51503
        • Methodist Jennie Edmundson Hospital
      • Creston, Iowa, Vereinigte Staaten, 50801
        • Greater Regional Medical Center
      • Des Moines, Iowa, Vereinigte Staaten, 50309
        • Iowa Methodist Medical Center
      • Des Moines, Iowa, Vereinigte Staaten, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Vereinigte Staaten, 50314
        • Broadlawns Medical Center
      • Des Moines, Iowa, Vereinigte Staaten, 50316
        • Iowa Lutheran Hospital
      • Des Moines, Iowa, Vereinigte Staaten, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Des Moines, Iowa, Vereinigte Staaten, 50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • Fort Dodge, Iowa, Vereinigte Staaten, 50501
        • McFarland Clinic - Trinity Cancer Center
      • Fort Dodge, Iowa, Vereinigte Staaten, 50501
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
      • Iowa City, Iowa, Vereinigte Staaten, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Jefferson, Iowa, Vereinigte Staaten, 50129
        • McFarland Clinic - Jefferson
      • Marshalltown, Iowa, Vereinigte Staaten, 50158
        • McFarland Clinic - Marshalltown
      • West Des Moines, Iowa, Vereinigte Staaten, 50266-7700
        • Methodist West Hospital
      • West Des Moines, Iowa, Vereinigte Staaten, 50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Garden City, Kansas, Vereinigte Staaten, 67846
        • Central Care Cancer Center - Garden City
      • Great Bend, Kansas, Vereinigte Staaten, 67530
        • Central Care Cancer Center - Great Bend
      • Hays, Kansas, Vereinigte Staaten, 67601
        • HaysMed
      • Lawrence, Kansas, Vereinigte Staaten, 66044
        • Lawrence Memorial Hospital
      • Olathe, Kansas, Vereinigte Staaten, 66061
        • The University of Kansas Cancer Center - Olathe
      • Overland Park, Kansas, Vereinigte Staaten, 66213
        • Saint Luke's South Hospital
      • Pittsburg, Kansas, Vereinigte Staaten, 66762
        • Freeman Physician Group of Pittsburg
      • Pittsburg, Kansas, Vereinigte Staaten, 66762
        • Mercy Hospital Pittsburg
      • Salina, Kansas, Vereinigte Staaten, 67401
        • Salina Regional Health Center
      • Topeka, Kansas, Vereinigte Staaten, 66606
        • University of Kansas Health System Saint Francis Campus
    • Kentucky
      • Bardstown, Kentucky, Vereinigte Staaten, 40004
        • CommonSpirit Saint Joseph Hospital - Bardstown
      • Corbin, Kentucky, Vereinigte Staaten, 40701
        • Commonwealth Cancer Center-Corbin
      • Lexington, Kentucky, Vereinigte Staaten, 40504
        • Saint Joseph Radiation Oncology Resource Center
      • Lexington, Kentucky, Vereinigte Staaten, 40509
        • CommonSpirit Saint Joseph Medical Center - East Lexington
      • Lexington, Kentucky, Vereinigte Staaten, 40504
        • CommonSpirit Saint Joseph Hospital - Lexington
      • London, Kentucky, Vereinigte Staaten, 40741
        • CommonSpirit Saint Joseph Hospital London
      • Louisville, Kentucky, Vereinigte Staaten, 40202
        • Jewish Hospital
      • Louisville, Kentucky, Vereinigte Staaten, 40245
        • UofL Health Medical Center Northeast
      • Louisville, Kentucky, Vereinigte Staaten, 40215
        • Saints Mary and Elizabeth Hospital
      • Mount Sterling, Kentucky, Vereinigte Staaten, 40353
        • CommonSpirit Saint Joseph Hospital Mount Sterling
      • Owensboro, Kentucky, Vereinigte Staaten, 42303
        • Owensboro Health Mitchell Memorial Cancer Center
      • Paducah, Kentucky, Vereinigte Staaten, 42003
        • Mercy Health - Paducah Cancer Center
      • Shepherdsville, Kentucky, Vereinigte Staaten, 40165
        • Jewish Hospital Medical Center South
    • Louisiana
      • Baton Rouge, Louisiana, Vereinigte Staaten, 70805
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge, Louisiana, Vereinigte Staaten, 70809
        • Louisiana Hematology Oncology Associates LLC
      • Baton Rouge, Louisiana, Vereinigte Staaten, 70809
        • Mary Bird Perkins Cancer Center
      • Baton Rouge, Louisiana, Vereinigte Staaten, 70808
        • Our Lady of The Lake
      • Baton Rouge, Louisiana, Vereinigte Staaten, 70808
        • Our Lady of the Lake Physician Group
      • Covington, Louisiana, Vereinigte Staaten, 70433
        • Northshore Oncology Associates-Covington
      • Houma, Louisiana, Vereinigte Staaten, 70360
        • Terrebonne General Medical Center
    • Maine
      • Augusta, Maine, Vereinigte Staaten, 04330
        • Harold Alfond Center for Cancer Care
      • Biddeford, Maine, Vereinigte Staaten, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Sanford, Maine, Vereinigte Staaten, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • South Portland, Maine, Vereinigte Staaten, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore, Maryland, Vereinigte Staaten, 21229
        • Saint Agnes Hospital
    • Massachusetts
      • Boston, Massachusetts, Vereinigte Staaten, 02118
        • Boston Medical Center
      • Worcester, Massachusetts, Vereinigte Staaten, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Adrian, Michigan, Vereinigte Staaten, 49221
        • Hickman Cancer Center
      • Ann Arbor, Michigan, Vereinigte Staaten, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek, Michigan, Vereinigte Staaten, 49017
        • Bronson Battle Creek
      • Brighton, Michigan, Vereinigte Staaten, 48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton, Michigan, Vereinigte Staaten, 48114
        • Trinity Health Medical Center - Brighton
      • Canton, Michigan, Vereinigte Staaten, 48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton, Michigan, Vereinigte Staaten, 48188
        • Trinity Health Medical Center - Canton
      • Caro, Michigan, Vereinigte Staaten, 48723
        • Caro Cancer Center
      • Chelsea, Michigan, Vereinigte Staaten, 48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea, Michigan, Vereinigte Staaten, 48118
        • Chelsea Hospital
      • Clarkston, Michigan, Vereinigte Staaten, 48346
        • Hematology Oncology Consultants-Clarkston
      • Clarkston, Michigan, Vereinigte Staaten, 48346
        • Newland Medical Associates-Clarkston
      • Detroit, Michigan, Vereinigte Staaten, 48236
        • Henry Ford Health Saint John Hospital
      • East China Township, Michigan, Vereinigte Staaten, 48054
        • Henry Ford River District Hospital
      • Flint, Michigan, Vereinigte Staaten, 48503
        • Hurley Medical Center
      • Flint, Michigan, Vereinigte Staaten, 48503
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Vereinigte Staaten, 48503
        • Genesys Hurley Cancer Institute
      • Flint, Michigan, Vereinigte Staaten, 48503
        • Cancer Hematology Centers - Flint
      • Grand Rapids, Michigan, Vereinigte Staaten, 49503
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, Vereinigte Staaten, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Grand Rapids, Michigan, Vereinigte Staaten, 49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Grosse Pointe Woods, Michigan, Vereinigte Staaten, 48236
        • Henry Ford Saint John Hospital - Academic
      • Grosse Pointe Woods, Michigan, Vereinigte Staaten, 48236
        • Henry Ford Saint John Hospital - Breast
      • Grosse Pointe Woods, Michigan, Vereinigte Staaten, 48236
        • Henry Ford Saint John Hospital - Van Elslander
      • Kalamazoo, Michigan, Vereinigte Staaten, 49007
        • West Michigan Cancer Center
      • Kalamazoo, Michigan, Vereinigte Staaten, 49007
        • Bronson Methodist Hospital
      • Kalamazoo, Michigan, Vereinigte Staaten, 49009
        • Beacon Kalamazoo Cancer Center
      • Kalamazoo, Michigan, Vereinigte Staaten, 49048
        • Beacon Kalamazoo
      • Lansing, Michigan, Vereinigte Staaten, 48912
        • University of Michigan Health - Sparrow Lansing
      • Livonia, Michigan, Vereinigte Staaten, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Livonia, Michigan, Vereinigte Staaten, 48154
        • Hope Cancer Clinic
      • Macomb, Michigan, Vereinigte Staaten, 48044
        • Henry Ford Warren Hospital - Breast Macomb
      • Macomb, Michigan, Vereinigte Staaten, 48044
        • Henry Ford Saint John Hospital - Macomb Medical
      • Marlette, Michigan, Vereinigte Staaten, 48453
        • Saint Mary's Oncology/Hematology Associates of Marlette
      • Monroe, Michigan, Vereinigte Staaten, 48162
        • Toledo Clinic Cancer Centers-Monroe
      • Muskegon, Michigan, Vereinigte Staaten, 49444
        • Trinity Health Muskegon Hospital
      • Niles, Michigan, Vereinigte Staaten, 49120
        • Corewell Health Lakeland Hospitals - Niles Hospital
      • Norton Shores, Michigan, Vereinigte Staaten, 49444
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
      • Novi, Michigan, Vereinigte Staaten, 48374
        • Henry Ford Health Providence Novi Hospital
      • Pontiac, Michigan, Vereinigte Staaten, 48341
        • Hope Cancer Center
      • Pontiac, Michigan, Vereinigte Staaten, 48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
      • Pontiac, Michigan, Vereinigte Staaten, 48341
        • Michigan Healthcare Professionals Pontiac
      • Pontiac, Michigan, Vereinigte Staaten, 48341
        • Trinity Health IHA Medical Group-Alice Gustafson Center
      • Reed City, Michigan, Vereinigte Staaten, 49677
        • Corewell Health Reed City Hospital
      • Rochester Hills, Michigan, Vereinigte Staaten, 48309
        • Henry Ford Rochester Hospital
      • Saginaw, Michigan, Vereinigte Staaten, 48604
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Vereinigte Staaten, 48601
        • MyMichigan Medical Center Saginaw
      • Saint Joseph, Michigan, Vereinigte Staaten, 49085
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
      • Saint Joseph, Michigan, Vereinigte Staaten, 49085
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
      • Southfield, Michigan, Vereinigte Staaten, 48075
        • Henry Ford Health Providence Southfield Hospital
      • Sterling Heights, Michigan, Vereinigte Staaten, 48312
        • Bhadresh Nayak MD PC-Sterling Heights
      • Tawas City, Michigan, Vereinigte Staaten, 48764
        • MyMichigan Medical Center Tawas
      • Traverse City, Michigan, Vereinigte Staaten, 49684
        • Munson Medical Center
      • Warren, Michigan, Vereinigte Staaten, 48088
        • Advanced Breast Care Center PLLC
      • Warren, Michigan, Vereinigte Staaten, 48093
        • Macomb Hematology Oncology PC
      • Warren, Michigan, Vereinigte Staaten, 48093
        • Henry Ford Madison Heights Hospital - Breast
      • Warren, Michigan, Vereinigte Staaten, 48093
        • Henry Ford Health Warren Hospital
      • Warren, Michigan, Vereinigte Staaten, 48093
        • Henry Ford Warren Hospital - GLCMS
      • West Branch, Michigan, Vereinigte Staaten, 48661
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Wyoming, Michigan, Vereinigte Staaten, 49519
        • University of Michigan Health - West
      • Ypsilanti, Michigan, Vereinigte Staaten, 48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
      • Ypsilanti, Michigan, Vereinigte Staaten, 48106
        • Huron Gastroenterology PC
    • Minnesota
      • Aitkin, Minnesota, Vereinigte Staaten, 56431
        • Riverwood Healthcare Center
      • Baxter, Minnesota, Vereinigte Staaten, 56425
        • Essentia Health - Baxter Clinic
      • Brainerd, Minnesota, Vereinigte Staaten, 56401
        • Essentia Health Saint Joseph's Medical Center
      • Burnsville, Minnesota, Vereinigte Staaten, 55337
        • Fairview Ridges Hospital
      • Burnsville, Minnesota, Vereinigte Staaten, 55337
        • Minnesota Oncology - Burnsville
      • Cambridge, Minnesota, Vereinigte Staaten, 55008
        • Cambridge Medical Center
      • Coon Rapids, Minnesota, Vereinigte Staaten, 55433
        • Mercy Hospital
      • Deer River, Minnesota, Vereinigte Staaten, 56636
        • Essentia Health - Deer River Clinic
      • Detroit Lakes, Minnesota, Vereinigte Staaten, 56501
        • Essentia Health Saint Mary's - Detroit Lakes Clinic
      • Duluth, Minnesota, Vereinigte Staaten, 55805
        • Essentia Health Cancer Center
      • Duluth, Minnesota, Vereinigte Staaten, 55805
        • Essentia Health Saint Mary's Medical Center
      • Duluth, Minnesota, Vereinigte Staaten, 55805
        • Miller-Dwan Hospital
      • Edina, Minnesota, Vereinigte Staaten, 55435
        • Fairview Southdale Hospital
      • Ely, Minnesota, Vereinigte Staaten, 55731
        • Essentia Health - Ely Clinic
      • Fergus Falls, Minnesota, Vereinigte Staaten, 56537
        • Lake Region Healthcare Corporation-Cancer Care
      • Fosston, Minnesota, Vereinigte Staaten, 56542
        • Essentia Health - Fosston
      • Fridley, Minnesota, Vereinigte Staaten, 55432
        • Unity Hospital
      • Hibbing, Minnesota, Vereinigte Staaten, 55746
        • Essentia Health Hibbing Clinic
      • International Falls, Minnesota, Vereinigte Staaten, 56649
        • Essentia Health - International Falls Clinic
      • Maple Grove, Minnesota, Vereinigte Staaten, 55369
        • Fairview Clinics and Surgery Center Maple Grove
      • Maplewood, Minnesota, Vereinigte Staaten, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, Vereinigte Staaten, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, Vereinigte Staaten, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, Vereinigte Staaten, 55407
        • Abbott-Northwestern Hospital
      • Minneapolis, Minnesota, Vereinigte Staaten, 55454
        • Health Partners Inc
      • Monticello, Minnesota, Vereinigte Staaten, 55362
        • Monticello Cancer Center
      • Moose Lake, Minnesota, Vereinigte Staaten, 55767
        • Essentia Health - Moose Lake Clinic
      • New Ulm, Minnesota, Vereinigte Staaten, 56073
        • New Ulm Medical Center
      • Park Rapids, Minnesota, Vereinigte Staaten, 56470
        • Essentia Health - Park Rapids
      • Princeton, Minnesota, Vereinigte Staaten, 55371
        • Fairview Northland Medical Center
      • Robbinsdale, Minnesota, Vereinigte Staaten, 55422
        • North Memorial Medical Health Center
      • Saint Louis Park, Minnesota, Vereinigte Staaten, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Paul, Minnesota, Vereinigte Staaten, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, Vereinigte Staaten, 55102
        • United Hospital
      • Sandstone, Minnesota, Vereinigte Staaten, 55072
        • Essentia Health Sandstone
      • Shakopee, Minnesota, Vereinigte Staaten, 55379
        • Saint Francis Regional Medical Center
      • Stillwater, Minnesota, Vereinigte Staaten, 55082
        • Lakeview Hospital
      • Virginia, Minnesota, Vereinigte Staaten, 55792
        • Essentia Health Virginia Clinic
      • Waconia, Minnesota, Vereinigte Staaten, 55387
        • Ridgeview Medical Center
      • Willmar, Minnesota, Vereinigte Staaten, 56201
        • Rice Memorial Hospital
      • Woodbury, Minnesota, Vereinigte Staaten, 55125
        • Minnesota Oncology Hematology PA-Woodbury
      • Wyoming, Minnesota, Vereinigte Staaten, 55092
        • Fairview Lakes Medical Center
    • Missouri
      • Ballwin, Missouri, Vereinigte Staaten, 63011
        • Mercy Oncology and Hematology - Clayton-Clarkson
      • Bolivar, Missouri, Vereinigte Staaten, 65613
        • Central Care Cancer Center - Bolivar
      • Branson, Missouri, Vereinigte Staaten, 65616
        • Cox Cancer Center Branson
      • Cape Girardeau, Missouri, Vereinigte Staaten, 63703
        • Saint Francis Medical Center
      • Cape Girardeau, Missouri, Vereinigte Staaten, 63703
        • Mercy Cancer Center - Cape Girardeau
      • City of Saint Peters, Missouri, Vereinigte Staaten, 63376
        • Siteman Cancer Center at Saint Peters Hospital
      • Columbia, Missouri, Vereinigte Staaten, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Creve Coeur, Missouri, Vereinigte Staaten, 63141
        • Siteman Cancer Center at West County Hospital
      • Farmington, Missouri, Vereinigte Staaten, 63640
        • Parkland Health Center - Farmington
      • Jefferson City, Missouri, Vereinigte Staaten, 65109
        • MU Health Care Goldschmidt Cancer Center
      • Joplin, Missouri, Vereinigte Staaten, 64804
        • Freeman Health System
      • Joplin, Missouri, Vereinigte Staaten, 64804
        • Mercy Hospital Joplin
      • Kansas City, Missouri, Vereinigte Staaten, 64111
        • Saint Luke's Hospital of Kansas City
      • Kansas City, Missouri, Vereinigte Staaten, 64108
        • University Health Truman Medical Center
      • Lee's Summit, Missouri, Vereinigte Staaten, 64086
        • Saint Luke's East - Lee's Summit
      • Rolla, Missouri, Vereinigte Staaten, 65401
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, Vereinigte Staaten, 65401
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, Vereinigte Staaten, 64506
        • Heartland Regional Medical Center
      • Sainte Genevieve, Missouri, Vereinigte Staaten, 63670
        • Sainte Genevieve County Memorial Hospital
      • Springfield, Missouri, Vereinigte Staaten, 65807
        • CoxHealth South Hospital
      • Springfield, Missouri, Vereinigte Staaten, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, Vereinigte Staaten, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Vereinigte Staaten, 63129
        • Siteman Cancer Center-South County
      • St Louis, Missouri, Vereinigte Staaten, 63136
        • Siteman Cancer Center at Christian Hospital
      • St Louis, Missouri, Vereinigte Staaten, 63131
        • Missouri Baptist Medical Center
      • St Louis, Missouri, Vereinigte Staaten, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, Vereinigte Staaten, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Vereinigte Staaten, 63128
        • Mercy Hospital South
      • Sullivan, Missouri, Vereinigte Staaten, 63080
        • Missouri Baptist Sullivan Hospital
      • Washington, Missouri, Vereinigte Staaten, 63090
        • Mercy Hospital Washington
    • Montana
      • Anaconda, Montana, Vereinigte Staaten, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, Vereinigte Staaten, 59101
        • Billings Clinic Cancer Center
      • Billings, Montana, Vereinigte Staaten, 59101
        • Saint Vincent Healthcare
      • Billings, Montana, Vereinigte Staaten, 59102
        • Saint Vincent Frontier Cancer Center
      • Bozeman, Montana, Vereinigte Staaten, 59715
        • Bozeman Health Deaconess Hospital
      • Great Falls, Montana, Vereinigte Staaten, 59405
        • Great Falls Clinic
      • Great Falls, Montana, Vereinigte Staaten, 59405
        • Benefis Sletten Cancer Institute
      • Kalispell, Montana, Vereinigte Staaten, 59901
        • Logan Health Medical Center
      • Missoula, Montana, Vereinigte Staaten, 59802
        • Saint Patrick Hospital - Community Hospital
      • Missoula, Montana, Vereinigte Staaten, 59804
        • Community Medical Center
    • Nebraska
      • Bellevue, Nebraska, Vereinigte Staaten, 68123
        • Nebraska Medicine-Bellevue
      • Grand Island, Nebraska, Vereinigte Staaten, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Kearney, Nebraska, Vereinigte Staaten, 68847
        • CHI Health Good Samaritan
      • Lincoln, Nebraska, Vereinigte Staaten, 68510
        • Saint Elizabeth Regional Medical Center
      • Omaha, Nebraska, Vereinigte Staaten, 68114
        • Nebraska Methodist Hospital
      • Omaha, Nebraska, Vereinigte Staaten, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Vereinigte Staaten, 68124
        • Alegent Health Bergan Mercy Medical Center
      • Omaha, Nebraska, Vereinigte Staaten, 68118
        • Nebraska Medicine-Village Pointe
      • Omaha, Nebraska, Vereinigte Staaten, 68122
        • Alegent Health Immanuel Medical Center
      • Omaha, Nebraska, Vereinigte Staaten, 68130
        • Alegent Health Lakeside Hospital
      • Omaha, Nebraska, Vereinigte Staaten, 68114
        • Oncology Associates PC
      • Omaha, Nebraska, Vereinigte Staaten, 68114
        • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
      • Papillion, Nebraska, Vereinigte Staaten, 68046
        • Midlands Community Hospital
    • Nevada
      • Carson City, Nevada, Vereinigte Staaten, 89703
        • Carson Tahoe Regional Medical Center
      • Henderson, Nevada, Vereinigte Staaten, 89052
        • Comprehensive Cancer Centers of Nevada - Henderson
      • Henderson, Nevada, Vereinigte Staaten, 89052
        • Cancer and Blood Specialists-Henderson
      • Henderson, Nevada, Vereinigte Staaten, 89052
        • Las Vegas Cancer Center-Henderson
      • Henderson, Nevada, Vereinigte Staaten, 89074
        • Comprehensive Cancer Centers of Nevada-Southeast Henderson
      • Henderson, Nevada, Vereinigte Staaten, 89052
        • Comprehensive Cancer Centers of Nevada-Horizon Ridge
      • Henderson, Nevada, Vereinigte Staaten, 89074
        • Las Vegas Urology - Green Valley
      • Henderson, Nevada, Vereinigte Staaten, 89074
        • Las Vegas Urology - Pebble
      • Henderson, Nevada, Vereinigte Staaten, 89074
        • Urology Specialists of Nevada - Green Valley
      • Henderson, Nevada, Vereinigte Staaten, 89074
        • Oncology Las Vegas - Henderson
      • Las Vegas, Nevada, Vereinigte Staaten, 89144
        • Summerlin Hospital Medical Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89109
        • Sunrise Hospital and Medical Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, Vereinigte Staaten, 89106
        • Radiation Oncology Centers of Nevada Central
      • Las Vegas, Nevada, Vereinigte Staaten, 89119
        • Radiation Oncology Centers of Nevada Southeast
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Comprehensive Cancer Centers of Nevada - Northwest
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • OptumCare Cancer Care at MountainView
      • Las Vegas, Nevada, Vereinigte Staaten, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, Vereinigte Staaten, 89144
        • Comprehensive Cancer Centers of Nevada - Town Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89144
        • Comprehensive Cancer Centers of Nevada-Summerlin
      • Las Vegas, Nevada, Vereinigte Staaten, 89148
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas, Nevada, Vereinigte Staaten, 89169
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas, Nevada, Vereinigte Staaten, 89102
        • University Medical Center of Southern Nevada
      • Las Vegas, Nevada, Vereinigte Staaten, 89106
        • Cancer and Blood Specialists-Shadow
      • Las Vegas, Nevada, Vereinigte Staaten, 89109
        • HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
      • Las Vegas, Nevada, Vereinigte Staaten, 89113
        • HealthCare Partners Medical Group Oncology/Hematology-San Martin
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Cancer and Blood Specialists-Tenaya
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • HealthCare Partners Medical Group Oncology/Hematology-Tenaya
      • Las Vegas, Nevada, Vereinigte Staaten, 89148-2405
        • Las Vegas Cancer Center-Medical Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89149
        • HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Ann M Wierman MD LTD
      • Las Vegas, Nevada, Vereinigte Staaten, 89074
        • Las Vegas Urology - Pecos
      • Las Vegas, Nevada, Vereinigte Staaten, 89102
        • Desert West Surgery
      • Las Vegas, Nevada, Vereinigte Staaten, 89103
        • Hope Cancer Care of Nevada
      • Las Vegas, Nevada, Vereinigte Staaten, 89106
        • Urology Specialists of Nevada - Central
      • Las Vegas, Nevada, Vereinigte Staaten, 89113
        • Las Vegas Prostate Cancer Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89113
        • Las Vegas Urology - Sunset
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Las Vegas Urology - Cathedral Rock
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Las Vegas Urology - Smoke Ranch
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Urology Specialists of Nevada - Northwest
      • Las Vegas, Nevada, Vereinigte Staaten, 89169
        • University Cancer Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89113
        • Urology Specialists of Nevada - Southwest
      • Las Vegas, Nevada, Vereinigte Staaten, 89128
        • Oncology Las Vegas - Tenaya
      • Las Vegas, Nevada, Vereinigte Staaten, 89183
        • OptumCare Cancer Care at Fort Apache
      • Pahrump, Nevada, Vereinigte Staaten, 89048
        • Hope Cancer Care of Nevada-Pahrump
      • Reno, Nevada, Vereinigte Staaten, 89502
        • Renown Regional Medical Center
      • Reno, Nevada, Vereinigte Staaten, 89503
        • Saint Mary's Regional Medical Center
      • Reno, Nevada, Vereinigte Staaten, 89509
        • Radiation Oncology Associates
    • New Hampshire
      • Concord, New Hampshire, Vereinigte Staaten, 03301
        • New Hampshire Oncology Hematology PA-Concord
      • Manchester, New Hampshire, Vereinigte Staaten, 03103
        • Solinsky Center for Cancer Care
      • Manchester, New Hampshire, Vereinigte Staaten, 03103
        • Elliot Hospital
    • New Jersey
      • Moorestown, New Jersey, Vereinigte Staaten, 08057
        • Virtua Samson Cancer Center
      • Mount Holly, New Jersey, Vereinigte Staaten, 08060
        • Virtua Memorial
      • Voorhees Township, New Jersey, Vereinigte Staaten, 08043
        • Virtua Voorhees
    • New Mexico
      • Albuquerque, New Mexico, Vereinigte Staaten, 87106
        • University of New Mexico Cancer Center
    • New York
      • Glens Falls, New York, Vereinigte Staaten, 12801
        • Glens Falls Hospital
      • The Bronx, New York, Vereinigte Staaten, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, Vereinigte Staaten, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, Vereinigte Staaten, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Kenansville, North Carolina, Vereinigte Staaten, 28349
        • ECU Health Oncology Kenansville
      • Kinston, North Carolina, Vereinigte Staaten, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, Vereinigte Staaten, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Richlands, North Carolina, Vereinigte Staaten, 28574
        • ECU Health Oncology Richlands
      • Washington, North Carolina, Vereinigte Staaten, 27889
        • Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
    • North Dakota
      • Fargo, North Dakota, Vereinigte Staaten, 58103
        • Essentia Health Cancer Center-South University Clinic
      • Jamestown, North Dakota, Vereinigte Staaten, 58401
        • Essentia Health - Jamestown Clinic
    • Ohio
      • Alliance, Ohio, Vereinigte Staaten, 44601
        • Aultman Alliance Community Hospital
      • Beavercreek, Ohio, Vereinigte Staaten, 45431
        • Indu and Raj Soin Medical Center
      • Boardman, Ohio, Vereinigte Staaten, 44512
        • Saint Elizabeth Boardman Hospital
      • Canton, Ohio, Vereinigte Staaten, 44708
        • Cleveland Clinic Mercy Hospital
      • Canton, Ohio, Vereinigte Staaten, 44710
        • Aultman Health Foundation
      • Centerville, Ohio, Vereinigte Staaten, 45459
        • Miami Valley Hospital South
      • Centerville, Ohio, Vereinigte Staaten, 45459
        • Dayton Physicians LLC-Miami Valley South
      • Cincinnati, Ohio, Vereinigte Staaten, 45220
        • Good Samaritan Hospital - Cincinnati
      • Cincinnati, Ohio, Vereinigte Staaten, 45242
        • Bethesda North Hospital
      • Cincinnati, Ohio, Vereinigte Staaten, 45236
        • Oncology Hematology Care Inc-Kenwood
      • Cincinnati, Ohio, Vereinigte Staaten, 45247
        • TriHealth Cancer Institute-Westside
      • Cincinnati, Ohio, Vereinigte Staaten, 45255
        • TriHealth Cancer Institute-Anderson
      • Cleveland, Ohio, Vereinigte Staaten, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Vereinigte Staaten, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Dayton, Ohio, Vereinigte Staaten, 45409
        • Miami Valley Hospital
      • Dayton, Ohio, Vereinigte Staaten, 45415
        • Miami Valley Hospital North
      • Dayton, Ohio, Vereinigte Staaten, 45415
        • Dayton Physician LLC - Englewood
      • Dayton, Ohio, Vereinigte Staaten, 45409
        • Premier Blood and Cancer Center
      • Findlay, Ohio, Vereinigte Staaten, 45840
        • Blanchard Valley Hospital
      • Findlay, Ohio, Vereinigte Staaten, 45840
        • Armes Family Cancer Center
      • Findlay, Ohio, Vereinigte Staaten, 45840
        • Orion Cancer Care
      • Franklin, Ohio, Vereinigte Staaten, 45005-1066
        • Atrium Medical Center-Middletown Regional Hospital
      • Franklin, Ohio, Vereinigte Staaten, 45005
        • Dayton Physicians LLC-Atrium
      • Greenville, Ohio, Vereinigte Staaten, 45331
        • Wayne Hospital
      • Greenville, Ohio, Vereinigte Staaten, 45331
        • Dayton Physicians LLC-Wayne
      • Greenville, Ohio, Vereinigte Staaten, 45331
        • Miami Valley Cancer Care and Infusion
      • Kettering, Ohio, Vereinigte Staaten, 45429
        • Kettering Medical Center
      • Kettering, Ohio, Vereinigte Staaten, 45409
        • Greater Dayton Cancer Center
      • Kettering, Ohio, Vereinigte Staaten, 45420
        • First Dayton Cancer Care
      • Mansfield, Ohio, Vereinigte Staaten, 44906
        • Cleveland Clinic Cancer Center Mansfield
      • Maumee, Ohio, Vereinigte Staaten, 43537
        • Toledo Clinic Cancer Centers-Maumee
      • Mayfield Heights, Ohio, Vereinigte Staaten, 44124
        • Hillcrest Hospital Cancer Center
      • Perrysburg, Ohio, Vereinigte Staaten, 43551
        • Mercy Health - Perrysburg Hospital
      • Sandusky, Ohio, Vereinigte Staaten, 44870
        • North Coast Cancer Care
      • Springfield, Ohio, Vereinigte Staaten, 45504
        • Springfield Regional Cancer Center
      • Springfield, Ohio, Vereinigte Staaten, 45504
        • Springfield Regional Medical Center
      • Strongsville, Ohio, Vereinigte Staaten, 44136
        • Cleveland Clinic Cancer Center Strongsville
      • Toledo, Ohio, Vereinigte Staaten, 43623
        • Mercy Health - Saint Anne Hospital
      • Toledo, Ohio, Vereinigte Staaten, 43623
        • Toledo Clinic Cancer Centers-Toledo
      • Troy, Ohio, Vereinigte Staaten, 45373
        • Upper Valley Medical Center
      • Troy, Ohio, Vereinigte Staaten, 45373
        • Dayton Physicians LLC - Troy
      • Warren, Ohio, Vereinigte Staaten, 44484
        • Saint Joseph Warren Hospital
      • Warrensville Heights, Ohio, Vereinigte Staaten, 44122
        • South Pointe Hospital
      • Wooster, Ohio, Vereinigte Staaten, 44691
        • Cleveland Clinic Wooster Family Health and Surgery Center
      • Wright-Patterson Air Force Base, Ohio, Vereinigte Staaten, 45433
        • Wright-Patterson Medical Center
      • Youngstown, Ohio, Vereinigte Staaten, 44501
        • Saint Elizabeth Youngstown Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, Vereinigte Staaten, 73120
        • Mercy Hospital Oklahoma City
    • Oregon
      • Baker City, Oregon, Vereinigte Staaten, 97814
        • Saint Alphonsus Cancer Care Center-Baker City
      • Bend, Oregon, Vereinigte Staaten, 97701
        • Saint Charles Health System
      • Clackamas, Oregon, Vereinigte Staaten, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Vereinigte Staaten, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Coos Bay, Oregon, Vereinigte Staaten, 97420
        • Bay Area Hospital
      • Newberg, Oregon, Vereinigte Staaten, 97132
        • Providence Newberg Medical Center
      • Ontario, Oregon, Vereinigte Staaten, 97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Oregon City, Oregon, Vereinigte Staaten, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Vereinigte Staaten, 97239
        • Oregon Health and Science University
      • Portland, Oregon, Vereinigte Staaten, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Vereinigte Staaten, 97225
        • Providence Saint Vincent Medical Center
      • Redmond, Oregon, Vereinigte Staaten, 97756
        • Saint Charles Health System-Redmond
    • Pennsylvania
      • Allentown, Pennsylvania, Vereinigte Staaten, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Allentown, Pennsylvania, Vereinigte Staaten, 18104
        • Saint Luke's Cancer Center - Allentown
      • Bethlehem, Pennsylvania, Vereinigte Staaten, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Bethlehem, Pennsylvania, Vereinigte Staaten, 18015
        • Saint Luke's University Hospital-Bethlehem Campus
      • Bryn Mawr, Pennsylvania, Vereinigte Staaten, 19010
        • Bryn Mawr Hospital
      • Chambersburg, Pennsylvania, Vereinigte Staaten, 17201
        • Chambersburg Hospital
      • Chambersburg, Pennsylvania, Vereinigte Staaten, 17201
        • WellSpan Medical Oncology and Hematology
      • Collegeville, Pennsylvania, Vereinigte Staaten, 19426
        • Main Line Health Center-Collegeville
      • East Stroudsburg, Pennsylvania, Vereinigte Staaten, 18301
        • Pocono Medical Center
      • Easton, Pennsylvania, Vereinigte Staaten, 18045
        • Saint Luke's Hospital-Anderson Campus
      • Ephrata, Pennsylvania, Vereinigte Staaten, 17522
        • Ephrata Cancer Center
      • Exton, Pennsylvania, Vereinigte Staaten, 19341
        • Main Line Health Center-Exton
      • Gettysburg, Pennsylvania, Vereinigte Staaten, 17325
        • Adams Cancer Center
      • Hanover, Pennsylvania, Vereinigte Staaten, 17331
        • WellSpan Medical Oncology and Hematology
      • Hazleton, Pennsylvania, Vereinigte Staaten, 18201
        • Lehigh Valley Hospital-Hazleton
      • Lebanon, Pennsylvania, Vereinigte Staaten, 17042
        • Sechler Family Cancer Center
      • Media, Pennsylvania, Vereinigte Staaten, 19063
        • Riddle Memorial Hospital
      • Newtown Square, Pennsylvania, Vereinigte Staaten, 19073
        • Bryn Mawr Health Center
      • Paoli, Pennsylvania, Vereinigte Staaten, 19301
        • Paoli Memorial Hospital
      • Philadelphia, Pennsylvania, Vereinigte Staaten, 19104
        • University of Pennsylvania/Abramson Cancer Center
      • Philadelphia, Pennsylvania, Vereinigte Staaten, 19104
        • Penn Presbyterian Medical Center
      • Pottstown, Pennsylvania, Vereinigte Staaten, 19464
        • Pottstown Hospital
      • Quakertown, Pennsylvania, Vereinigte Staaten, 18951
        • Saint Luke's Hospital-Quakertown Campus
      • Quakertown, Pennsylvania, Vereinigte Staaten, 18951
        • Saint Luke's Hospital - Upper Bucks Campus
      • Sayre, Pennsylvania, Vereinigte Staaten, 18840
        • Guthrie Medical Group PC-Robert Packer Hospital
      • Wynnewood, Pennsylvania, Vereinigte Staaten, 19096
        • Lankenau Medical Center
      • York, Pennsylvania, Vereinigte Staaten, 17403
        • WellSpan Health-York Cancer Center
      • York, Pennsylvania, Vereinigte Staaten, 17403
        • WellSpan Health-York Hospital
      • York, Pennsylvania, Vereinigte Staaten, 17403
        • Cancer Care Associates of York
    • South Carolina
      • Greenwood, South Carolina, Vereinigte Staaten, 29646
        • Self Regional Healthcare
    • Texas
      • Bryan, Texas, Vereinigte Staaten, 77802
        • Saint Joseph Regional Cancer Center
    • Virginia
      • Mechanicsville, Virginia, Vereinigte Staaten, 23116
        • Bon Secours Memorial Regional Medical Center
      • Midlothian, Virginia, Vereinigte Staaten, 23114
        • Bon Secours Saint Francis Medical Center
      • Midlothian, Virginia, Vereinigte Staaten, 23113
        • Bon Secours Westchester Emergency Center
      • Norfolk, Virginia, Vereinigte Staaten, 23505
        • Bon Secours DePaul Medical Center
      • Portsmouth, Virginia, Vereinigte Staaten, 23707
        • Bon Secours Maryview Medical Center
      • Richmond, Virginia, Vereinigte Staaten, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, Vereinigte Staaten, 23226
        • Bon Secours Saint Mary's Hospital
      • Richmond, Virginia, Vereinigte Staaten, 23230
        • Bon Secours Cancer Institute at Reynolds Crossing
      • Richmond, Virginia, Vereinigte Staaten, 23223
        • Bon Secours Richmond Community Hospital
      • Richmond, Virginia, Vereinigte Staaten, 23298
        • VCU Massey Comprehensive Cancer Center
      • Suffolk, Virginia, Vereinigte Staaten, 23435
        • Bon Secours Health Center at Harbour View
    • Washington
      • Aberdeen, Washington, Vereinigte Staaten, 98520
        • Providence Regional Cancer System-Aberdeen
      • Bellevue, Washington, Vereinigte Staaten, 98004
        • Overlake Medical Center
      • Bellingham, Washington, Vereinigte Staaten, 98225
        • PeaceHealth Saint Joseph Medical Center
      • Burien, Washington, Vereinigte Staaten, 98166
        • Saint Anne Hospital
      • Centralia, Washington, Vereinigte Staaten, 98531
        • Providence Regional Cancer System-Centralia
      • Edmonds, Washington, Vereinigte Staaten, 98026
        • Swedish Cancer Institute-Edmonds
      • Enumclaw, Washington, Vereinigte Staaten, 98022
        • Saint Elizabeth Hospital
      • Everett, Washington, Vereinigte Staaten, 98201
        • Providence Regional Cancer Partnership
      • Federal Way, Washington, Vereinigte Staaten, 98003
        • Saint Francis Hospital
      • Issaquah, Washington, Vereinigte Staaten, 98029
        • Swedish Cancer Institute-Issaquah
      • Kennewick, Washington, Vereinigte Staaten, 99336
        • Kadlec Clinic Hematology and Oncology
      • Lacey, Washington, Vereinigte Staaten, 98503
        • Providence Regional Cancer System-Lacey
      • Lakewood, Washington, Vereinigte Staaten, 98499
        • Saint Clare Hospital
      • Longview, Washington, Vereinigte Staaten, 98632
        • PeaceHealth Saint John Medical Center
      • Port Townsend, Washington, Vereinigte Staaten, 98368
        • Jefferson Healthcare
      • Poulsbo, Washington, Vereinigte Staaten, 98370
        • Harrison HealthPartners Hematology and Oncology-Poulsbo
      • Renton, Washington, Vereinigte Staaten, 98055
        • Valley Medical Center
      • Seattle, Washington, Vereinigte Staaten, 98107
        • Swedish Medical Center-Ballard Campus
      • Seattle, Washington, Vereinigte Staaten, 98122
        • Swedish Medical Center-First Hill
      • Seattle, Washington, Vereinigte Staaten, 98104
        • Pacific Gynecology Specialists
      • Seattle, Washington, Vereinigte Staaten, 98122-5711
        • Swedish Medical Center-Cherry Hill
      • Sedro-Woolley, Washington, Vereinigte Staaten, 98284
        • PeaceHealth United General Medical Center
      • Shelton, Washington, Vereinigte Staaten, 98584
        • Providence Regional Cancer System-Shelton
      • Silverdale, Washington, Vereinigte Staaten, 98383
        • Saint Joseph Medical Center Hematology and Oncology - Silverdale
      • Tacoma, Washington, Vereinigte Staaten, 98405
        • Northwest Medical Specialties PLLC
      • Tacoma, Washington, Vereinigte Staaten, 98405
        • Franciscan Research Center-Northwest Medical Plaza
      • Vancouver, Washington, Vereinigte Staaten, 98664
        • PeaceHealth Southwest Medical Center
      • Walla Walla, Washington, Vereinigte Staaten, 99362
        • Providence Saint Mary Regional Cancer Center
      • Yakima, Washington, Vereinigte Staaten, 98902
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
      • Yelm, Washington, Vereinigte Staaten, 98597
        • Providence Regional Cancer System-Yelm
    • West Virginia
      • Huntington, West Virginia, Vereinigte Staaten, 25701
        • Edwards Comprehensive Cancer Center
    • Wisconsin
      • Appleton, Wisconsin, Vereinigte Staaten, 54911
        • ThedaCare Regional Cancer Center
      • Ashland, Wisconsin, Vereinigte Staaten, 54806
        • Duluth Clinic Ashland
      • Ashland, Wisconsin, Vereinigte Staaten, 54806
        • Northwest Wisconsin Cancer Center
      • Berlin, Wisconsin, Vereinigte Staaten, 54923
        • ThedaCare Cancer Care - Berlin
      • Burlington, Wisconsin, Vereinigte Staaten, 53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Chippewa Falls, Wisconsin, Vereinigte Staaten, 54729
        • Marshfield Clinic-Chippewa Center
      • Cudahy, Wisconsin, Vereinigte Staaten, 53110
        • Aurora Saint Luke's South Shore
      • Eau Claire, Wisconsin, Vereinigte Staaten, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Germantown, Wisconsin, Vereinigte Staaten, 53022
        • Aurora Health Care Germantown Health Center
      • Grafton, Wisconsin, Vereinigte Staaten, 53024
        • Aurora Cancer Care-Grafton
      • Green Bay, Wisconsin, Vereinigte Staaten, 54311
        • Aurora BayCare Medical Center
      • Hayward, Wisconsin, Vereinigte Staaten, 54843
        • Essentia Health-Hayward Clinic
      • Kenosha, Wisconsin, Vereinigte Staaten, 53142
        • Aurora Cancer Care-Kenosha South
      • La Crosse, Wisconsin, Vereinigte Staaten, 54601
        • Gundersen Lutheran Medical Center
      • Ladysmith, Wisconsin, Vereinigte Staaten, 54848
        • Marshfield Medical Center - Ladysmith
      • Marinette, Wisconsin, Vereinigte Staaten, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marshfield, Wisconsin, Vereinigte Staaten, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Vereinigte Staaten, 53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee, Wisconsin, Vereinigte Staaten, 53215
        • Aurora Saint Luke's Medical Center
      • Milwaukee, Wisconsin, Vereinigte Staaten, 53233
        • Aurora Sinai Medical Center
      • Minocqua, Wisconsin, Vereinigte Staaten, 54548
        • Marshfield Medical Center - Minocqua
      • Mukwonago, Wisconsin, Vereinigte Staaten, 53149
        • ProHealth D N Greenwald Center
      • New Richmond, Wisconsin, Vereinigte Staaten, 54017
        • Cancer Center of Western Wisconsin
      • Oconomowoc, Wisconsin, Vereinigte Staaten, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oshkosh, Wisconsin, Vereinigte Staaten, 54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Racine, Wisconsin, Vereinigte Staaten, 53406
        • Aurora Cancer Care-Racine
      • Rice Lake, Wisconsin, Vereinigte Staaten, 54868
        • Marshfield Medical Center-Rice Lake
      • Sheboygan, Wisconsin, Vereinigte Staaten, 53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Spooner, Wisconsin, Vereinigte Staaten, 54801
        • Essentia Health-Spooner Clinic
      • Stevens Point, Wisconsin, Vereinigte Staaten, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Summit, Wisconsin, Vereinigte Staaten, 53066
        • Aurora Medical Center in Summit
      • Superior, Wisconsin, Vereinigte Staaten, 54880
        • Essentia Health Saint Mary's Hospital - Superior
      • Two Rivers, Wisconsin, Vereinigte Staaten, 54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Waukesha, Wisconsin, Vereinigte Staaten, 53188
        • UW Cancer Center at ProHealth Care
      • Waukesha, Wisconsin, Vereinigte Staaten, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wausau, Wisconsin, Vereinigte Staaten, 54401
        • Marshfield Clinic-Wausau Center
      • Wauwatosa, Wisconsin, Vereinigte Staaten, 53226
        • Aurora Cancer Care-Milwaukee West
      • Weston, Wisconsin, Vereinigte Staaten, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, Vereinigte Staaten, 54494
        • Marshfield Clinic - Wisconsin Rapids Center
    • Wyoming
      • Cheyenne, Wyoming, Vereinigte Staaten, 82001
        • Cheyenne Regional Medical Center-West
      • Cody, Wyoming, Vereinigte Staaten, 82414
        • Billings Clinic-Cody
      • Sheridan, Wyoming, Vereinigte Staaten, 82801
        • Welch Cancer Center

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • RANDOMIZATION (STEP 1): Patient must be >= 18 years of age

  • RANDOMIZATION (STEP 1): Patient must have pathologically confirmed non-squamous non-small cell lung carcinoma (NSCLC). Patients with NSCLC not otherwise specified (NOS) are eligible. Mixed tumors will be categorized by predominant cell type. If small cell elements are present, the patient is ineligible

  • RANDOMIZATION (STEP 1): Patient must have metastatic stage IVA or IVB disease (includes M1a, M1b, and M1c), according to the 8th edition of the lung cancer TNM classification system. Recurrent metastatic NSCLC ineligible for curative therapy (in the treating investigator's opinion) is also allowed

  • RANDOMIZATION (STEP 1): Patient's tumor must be known negative for EGFR tyrosine kinase inhibitor (TKI) sensitizing mutations (for example at a minimum, negative for EGFR Exon 19 deletions, EGFR exon 20 insertions, and Exon 21 L858R, L861Q mutations ) AND negative for ALK gene rearrangements (by fluorescence in situ hybridization [FISH], next generation sequencing [NGS], or immunohistochemistry [IHC]) by routine Clinical Laboratory Improvement Amendments (CLIA)- or Food and Drug Administration (FDA)-certified clinical testing methods. CLIA or FDA approved circulating tumor deoxyribonucleic acid (DNA) testing is acceptable as an alternative to tissue testing

  • RANDOMIZATION (STEP 1): Patient must have radiographic and/or clinical progression (per local investigator assessment) following one, but only one, line of platinum-based chemotherapy AND one, but only one, line of prior checkpoint inhibitor (anti-PD-1 or PD-L1) immunotherapy, either concurrently or sequentially in either order. A minimum of two doses of prior immunotherapy is required. Only one prior line of therapy is allowed if patients received chemotherapy and immunotherapy together (patients may not receive subsequent single agent chemotherapy), and greater than two prior lines of therapy are not allowed.

    • NOTE: Lines of therapy are defined by clinical or radiographic progression. For patients with recurrent metastatic NSCLC following treatment for stage 1-3 NSCLC, platinum-based chemotherapy received within 12 months of recurrence and/or immunotherapy received within 6 months of recurrence will meet the requirement for prior chemotherapy and/or immunotherapy but subsequent receipt of more immunotherapy and/or platinum-based chemotherapy is also allowed.
    • NOTE: Prior anti-VEGF antibody therapy (ie bevacizumab) is allowed. Prior ipilimumab, or investigational agents not excluded below, in combination with the required prior therapies above are allowed.
    • NOTE: Prior receipt of one or two lines of targeted therapy for ROS1, RET, MET, BRAF, ERBB2/HER2, or KRAS G12C positive NSCLC is allowed and will not count toward the line of therapy limit. However, progression is still required after chemotherapy and immunotherapy as above. Patients with ROS1, RET, MET positive NSCLC are strongly encouraged to get appropriate targeted therapy (such as crizotinib, entrectinib, lorlatinib, selpercatinib, pralsetinib, capmatinib, tepotinib, or another investigational, off-label, or approved agent directed against ROS1, RET, or MET positive NSCLC) prior to participation and will be stratified.
    • NOTE: No prior predominantly VEGFR directed TKI therapy (such as cabozantinib, lenvatinib, or sitravantinib) is allowed, except for the agents named above.
  • RANDOMIZATION (STEP 1): The investigator must document the intended chemotherapy regimen should their patient be randomized to Arm C (docetaxel and ramucirumab, OR single agent chemotherapy - docetaxel, gemcitabine, paclitaxel, nab-paclitaxel). The patient must not have received the selected chemotherapy agent previously for metastatic disease

  • RANDOMIZATION (STEP 1): Any prior chemotherapy (based on administration schedule) must have been completed in greater than or equal to the following times prior to randomization:

    • FDA approved targeted oral therapy must be completed >= 1 week prior
    • Chemotherapy and/or immunotherapy must be completed >= 2 weeks prior
    • Prior investigational agents must be completed >= 4 weeks prior.
  • RANDOMIZATION (STEP 1): Prior radiation therapy is allowed with a 2 week washout prior to randomization. Patient must not receive any systemic treatment with radionuclides within 6 weeks prior to randomization. Patient must have no clinically relevant ongoing complication from prior radiation therapy

  • RANDOMIZATION (STEP 1): Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen (in the opinion of the treating physician) are eligible for this trial

  • RANDOMIZATION (STEP 1): Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents (such as anthracycline or HER2-directed antibody therapy, but not prior checkpoint inhibitor therapy), must have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients must be class 2B or better

  • RANDOMIZATION (STEP 1): Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have met the eligibility criteria outlined above

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have measurable disease as defined by RECIST v1.1. Measurements must be obtained within 4 weeks prior to randomization/registration

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have recovered to equal to or less than grade 1 toxicities related to prior treatment, unless toxicities are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Platelets >= 100,000/mcL (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (for patients with Gilbert's disease total bilirubin must be =< 3 x ULN) (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Aspartate aminotransferase (AST)(serum glutamic oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73m^2 (normalized to body surface area [BSA]) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 X ULN or creatinine clearance >= 50ml/min/1.73m^2 (obtained within 2 weeks prior to randomization)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not be pregnant or breast-feeding due to the unknown effects of cabozantinib and nivolumab on human development and for the potential risk for adverse events in nursing infants with the treatment regimens being used.

    • All patients of childbearing potential must have a blood test or urine study within 14 days prior to randomization/registration to rule out pregnancy.
    • A patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after completion of treatment on the study

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have clinically significant gastrointestinal bleeding within 6 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have pulmonary hemorrhage or hemoptysis of >= 0.5 teaspoon (2.5 mL) of red blood within 3 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have active drug induced pneumonitis within 3 months prior to randomization. Prior immune mediated pneumonitis of grade 3 or 4 are not eligible regardless of time window

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have current radiographic evidence of tumor invading major blood vessel, evidence of tumor cavitation > 1 cm, evidence of tumor invading the gastrointestinal (GI) tract (esophagus, stomach, small or large bowel, rectum or anus), or evidence of endotracheal or mainstem endobronchial tumor

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have peptic ulcer disease, known malabsorption syndrome, bowel obstruction or gastric outlet obstruction within 3 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have abdominal fistula, GI perforation, or intra-abdominal abscess within 6 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have grade 3 or greater infection, or infection requiring intravenous systemic treatment within 14 days prior to randomization. Patients must be off antibiotics at the time of randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have serious non-healing wound/ulcer/bone fracture within 28 days prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have history of organ transplant

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have concurrent symptomatic untreated hypothyroidism

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have history of major surgery within 3 months prior to randomization, minor surgery within 28 days prior to randomization, other minor procedures within 7 days prior to randomization, or clinically relevant ongoing complications from prior procedures

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have concurrent uncontrolled hypertension defined as sustained blood pressure (BP) > 160 mm Hg systolic, or > 100 mm Hg diastolic despite optimal antihypertensive treatment

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have unstable angina pectoris, clinically-significant cardiac arrhythmias, stroke (including transient ischemic attack [TIA]), or myocardial infarction within 6 months prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients must not have a diagnosis of deep vein thrombosis/pulmonary embolism (DVT/PE) within 6 months of randomization unless stable, asymptomatic, and treated with low-molecular-weight heparin (LMWH) or a permitted oral anticoagulant for at least 7 days before randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not be receiving anticoagulants (i.e., warfarin, aspirin, clopidogrel) except:

    • Prophylactic use of low-dose aspirin (100 mg po daily or less) and/or low dose molecular weight heparin (LMWH) is permitted.
    • Therapeutic doses of low dose molecular weight heparin (LMWH) or specified direct factor Xa inhibitors rivaroxaban, edoxaban, or apixaban are allowed in patients without untreated brain metastases who are on a stable dose 7 days prior to study randomization, and without clinically significant hemorrhagic complications from the anticoagulation regimen or the tumor
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not receive strong CYP3A4 inducers (e.g., dexamethasone (> 1 mg daily dosing), phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital, and St. John's Wort) within 7 days prior to randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 msec within 28 days prior to Step 1 randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must be able to swallow tablets

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not be on continuous systemic treatment with corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 7 days prior to randomization, with the following exceptions:

    • Inhaled or topical steroids and adrenal replacement doses =< 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.
    • Patients are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption).
    • Physiologic replacement doses of systemic corticosteroids are permitted, if < 10 mg/day prednisone equivalents. A brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen) is permitted
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with brain metastases are eligible as follows:

    • Previously treated brain metastases must have been treated with radiation > 2 weeks prior to randomization or surgery > 3 months prior to randomization OR
    • Untreated (active) brain metastases are allowed if they are clinically asymptomatic, < 1 cm, non-hemorrhagic, the patient is not on systemic anticoagulation, and the investigator believes that central nervous system (CNS) specific treatment is unlikely to be required during the first 3 months of study treatment.
    • NOTE: Symptomatic leptomeningeal disease is NOT allowed
  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not have known active autoimmune disease or known history of autoimmune disease for which recurrence may affect vital organ function or require immune suppressive treatment including systemic corticosteroids (e.g., immune-related neurologic disease, multiple sclerosis, autoimmune neuropathy, Guillain-Barre syndrome, etc.).

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with known history of human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with known history of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral at time of randomization (suppressive therapy is allowed, if indicated)

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patients with a known history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load at time of randomization

  • RANDOMIZATION (STEP 1 - ALL TREATMENT ARMS): Patient must not have had any prior allergic reaction or hypersensitivity to study drug components or related drugs (multitargeted small molecule tyrosine kinase inhibitors or checkpoint inhibitor monoclonal antibodies)

  • STEP 2 (CROSSOVER ARM Z): Patient must have met all eligibility requirements for Step 1 at time of registration to Step 1 to be eligible for Step 2

  • STEP 2 (CROSSOVER ARM Z): Patient must have radiographic progressive disease per RECIST criteria after >= 2 cycles of therapy on Arm C. The scan showing progression must be completed within 6 weeks prior to Step 2 registration

  • STEP 2 (CROSSOVER ARM Z): Patient must not have intervening anticancer treatment or major surgical procedure(s) between Step 1 and Step 2, except palliative radiation which was completed >= 1 week prior to registration to Step 2

  • STEP 2 (CROSSOVER ARM Z): Patient may not have central nervous system progression, but patients with stable CNS disease are allowed

  • STEP 2 (CROSSOVER ARM Z): Patient must have an ECOG performance status 0-2

  • STEP 2 (CROSSOVER ARM Z): Patient must have recovered to equal to or less than grade 1 toxicities related to prior treatment, unless the adverse event(s) are clinically non significant and/or stable on supportive therapy (as determined by the treating physician)

  • STEP 2 (CROSSOVER ARM Z): Absolute neutrophil count >= 1,500/mcL (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Platelets >= 100,000/mcL (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Hemoglobin >= 9 g/dL (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Total bilirubin =< 1.5 x institutional ULN (for patients with Gilbert's disease total bilirubin must be =< 3 x ULN) (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): AST(SGOT) and ALT(SGPT) =< 2.5 x ULN (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Creatinine =< 1.5 x ULN OR calculated (Cockcroft-Gault formula) or measured creatinine clearance >= 50 mL/min/1.73m^2 (normalized to BSA) for patients with creatinine levels greater than 1.5 times the institutional normal creatinine =< 1.5 X ULN or creatinine clearance >= 50ml/min/1.73m^2 (obtained within 2 weeks prior to registration to Step 2)

  • STEP 2 (CROSSOVER ARM Z): Patient must have corrected QT interval calculated by the Fridericia formula (QTcF) =< 500 ms within 28 days prior to Step 2 registration

  • STEP 2 (CROSSOVER ARM Z): Patient must not have any intercurrent illness or disease complication that the investigator believes would limit the ability to safely tolerate the combination of cabozantinib and nivolumab

  • STEP 2 (CROSSOVER ARM Z): Patient must not be pregnant or breast-feeding due to the unknown effects of cabozantinib and nivolumab on human development and for the potential risk for adverse events in nursing infants with the treatment regimens being used.

    • All patients of childbearing potential must have a blood test or urine study within 14 days prior to registration to Step 2 to rule out pregnancy.
    • A patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
  • STEP 2 (CROSSOVER ARM Z): Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after completion of treatment on the study

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Step 1, Arm A (cabozantinib S-malate)

Patients in Step 1, Arm A receive cabozantinib S-malate PO QD. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Undergo CT

Andere Namen:
  • CT
  • KATZE
  • Computertomographie
  • Computergestützte axiale Tomographie
  • CT-Scan
  • Tomographie
  • Computerisierte Axialtomographie (Verfahren)
  • Computertomographie (CT)-Scan
  • Diagnosekatze Scan
  • Diagnose -Katzen -Scan -Service -Typ

Given PO

Andere Namen:
  • BMS-907351
  • Cabometyx
  • Cometriq
  • XL-184
  • XL184

Undergo ECHO

Andere Namen:
  • Echokardiographie
  • EG

Undergo blood collection

Andere Namen:
  • Biologische Probensammlung
  • Bioprobe gesammelt
  • Probenentnahme
  • Beispielsammlung
Experimental: Step 1, Arm B (cabozantinib S-malate, nivolumab)

Patients in Step 1, Arm B receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Undergo CT

Andere Namen:
  • CT
  • KATZE
  • Computertomographie
  • Computergestützte axiale Tomographie
  • CT-Scan
  • Tomographie
  • Computerisierte Axialtomographie (Verfahren)
  • Computertomographie (CT)-Scan
  • Diagnosekatze Scan
  • Diagnose -Katzen -Scan -Service -Typ

Given PO

Andere Namen:
  • BMS-907351
  • Cabometyx
  • Cometriq
  • XL-184
  • XL184

Undergo ECHO

Andere Namen:
  • Echokardiographie
  • EG

Given IV

Andere Namen:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumab-Biosimilar CMAB819
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumab Biosimilar ABP 206
  • BCD-263
  • Nivolumab-Biosimilar BCD-263
  • BMS936558
  • ONO 4538
  • ONO4538

Undergo blood collection

Andere Namen:
  • Biologische Probensammlung
  • Bioprobe gesammelt
  • Probenentnahme
  • Beispielsammlung
Aktiver Komparator: Step 1, Arm C (standard chemotherapy)

Patients in Step 1, Arm C receive ramucirumab IV over 30-60 minutes and docetaxel IV over 1 hour on day 1, or docetaxel IV over 1 hour on days 1 and 8, or gemcitabine hydrochloride IV on days 1 and 8, or paclitaxel IV over 3 hours on day 1, or nab-paclitaxel IV over 30 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity and at the discretion of the treating physician. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Given IV

Andere Namen:
  • Taxol
  • Anzatax
  • Asotax
  • Bristolxol
  • Praxel
  • Taxol Konzentrat

Given IV

Andere Namen:
  • Taxotere
  • Docecad
  • RP56976
  • Taxotere Injektionskonzentrat
  • RP-56976

Undergo CT

Andere Namen:
  • CT
  • KATZE
  • Computertomographie
  • Computergestützte axiale Tomographie
  • CT-Scan
  • Tomographie
  • Computerisierte Axialtomographie (Verfahren)
  • Computertomographie (CT)-Scan
  • Diagnosekatze Scan
  • Diagnose -Katzen -Scan -Service -Typ

Undergo ECHO

Andere Namen:
  • Echokardiographie
  • EG

Undergo blood collection

Andere Namen:
  • Biologische Probensammlung
  • Bioprobe gesammelt
  • Probenentnahme
  • Beispielsammlung

Given IV

Andere Namen:
  • ABI-007
  • Abraxane
  • Albumingebundenes Paclitaxel
  • ABI007
  • Albumin-stabilisiertes Nanopartikel Paclitaxel
  • Nanopartikel-albumingebundenes Paclitaxel
  • Nanopartikel Paclitaxel
  • Paclitaxel-Albumin
  • Paclitaxel Albumin-stabilisierte Nanopartikel-Formulierung
  • Proteingebundenes Paclitaxel
  • Albumingebundene Paclitaxel-Nanopartikel
  • Naveruclif

Given PO

Andere Namen:
  • Gemzar
  • dFdCyd
  • Difluordesoxycytidinhydrochlorid
  • Gemcitabin HCl
  • LY-188011
  • LY188011
  • LY 188011

Given IV

Andere Namen:
  • LY3009806
  • IMC-1121B
  • Cyramza
  • Vollständig humaner monoklonaler Anti-VEGFR-2-Antikörper IMC-1121B
  • Monoklonaler Antikörper HGS-ETR2
  • IMC1121B
  • LY-3009806
Experimental: Step 2, Arm Z (cabozantinib S-malate, nivolumab)

Patients in Step 2, Arm Z receive cabozantinib S-malate PO QD and nivolumab IV over 30 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients may continue to receive therapy after investigator-assessed RECIST 1.1 defined progression, including stable clinical and performance status and have potential for continued clinical benefit. Patients also undergo ECHO as clinically indicated, CT throughout the trial, and collection of blood on study.

Undergo CT

Andere Namen:
  • CT
  • KATZE
  • Computertomographie
  • Computergestützte axiale Tomographie
  • CT-Scan
  • Tomographie
  • Computerisierte Axialtomographie (Verfahren)
  • Computertomographie (CT)-Scan
  • Diagnosekatze Scan
  • Diagnose -Katzen -Scan -Service -Typ

Given PO

Andere Namen:
  • BMS-907351
  • Cabometyx
  • Cometriq
  • XL-184
  • XL184

Undergo ECHO

Andere Namen:
  • Echokardiographie
  • EG

Given IV

Andere Namen:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumab-Biosimilar CMAB819
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumab Biosimilar ABP 206
  • BCD-263
  • Nivolumab-Biosimilar BCD-263
  • BMS936558
  • ONO 4538
  • ONO4538

Undergo blood collection

Andere Namen:
  • Biologische Probensammlung
  • Bioprobe gesammelt
  • Probenentnahme
  • Beispielsammlung

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Progression-free survival (PFS) for patient population with non-squamous no-small cell lung cancer (NSCLC)
Zeitfenster: After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first)

The final analysis of PFS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). The two primary comparisons of PFS will each use a logrank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of PFS including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. At the final analyses, in the event that both primary PFS comparisons of the combination of nivolumab with cabozantinib and cabozantinib alone versus the standard chemotherapy are statistically significant, PFS will be compared between the two experimental arms (combination of nivolumab with cabozantinib versus [vs.] cabozantinib alone), using a stratified log rank test with a one-sided type I error rate of 10%.

After 58 events (From time of randomization to documented disease progression [site review of imaging] or death from any cause, whichever occurs first)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Overall survival (OS) for each arm
Zeitfenster: From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years

The final analysis of OS will be performed when the full information of PFS is reached (i.e., 58 events for each of the two primary comparisons). OS will be tested in a hierarchical fashion if the primary comparison of PFS between treatment arms is statistically significant, using a log rank test stratified on the randomization stratification factors with a one-sided type I error rate of 10%. Estimates of OS, including medians and confidence intervals, will be calculated using the Kaplan-Meier method. Cox proportional hazards models, stratified, on the same factors, will be used to estimate the treatment hazard ratios. OS will be further tested in a hierarchical fashion if the comparison of PFS between the two experimental arms is statistically significant. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals. Subset analyses of PFS and OS by treatment arm will be estimated and compared within subsets.

From time of randomization to documented disease progression (site review of imaging) or death from any cause, whichever occurs first, assessed up to 3 years
Best objective response for each arm
Zeitfenster: Every 6 weeks for the first year on study, and then every 12 weeks after year one

Will be evaluated via Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. Response rates (complete response [CR] + partial response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals.

Every 6 weeks for the first year on study, and then every 12 weeks after year one
Toxicity profile of monotherapy with cabozantinib, and the combination of nivolumab and cabozantinib
Zeitfenster: Up to 3 years after completion of study treatment

Will be determined using the Common Terminology Criteria for Adverse Events (CTCAE) criteria. Response rates (complete response [CR] + pathologic response [PR]) and toxicity will be compared using Fisher's exact tests with a one-sided type I error rate of 10%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes. Modeling procedures will implement backward selection; variables significant at the 0.10 level in the univariate setting will be chosen for inclusion in an initial full model, and at each step the least significant variable will be removed from the model. Only those covariates with p < 0.05 will remain in any final models, unless there are factors identified by the study team as crucial to model interpretation. Point estimates of all endpoints will be accompanied by the corresponding two-sided 80% confidence intervals.

Up to 3 years after completion of study treatment

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
The RECIST1.1 response at each time point
Zeitfenster: Every 6 weeks for the first year on study, and then every 12 weeks after year one

The measurement of each time point will be performed using the revised CHOI criteria will be only applied to arms A and B, which will include anti-angiogenic therapy. Both the RECIST1.1 and revised CHOI criteria will assess the overall best response as CR, partial PR, stable disease (SD), or progressive disease (PD). Their concordance will be assessed using the weighted Cohen's kappa coefficient (k) with quadratic weights. As a rule of thumb, the level of concordance between the two criteria will be considered poor (k <0), slight (k 0-0.20), fair (k 0.21-0.40), moderate (k 0.41-0.60), substantial (k 0.61-0.80), and almost perfect (k 0.81 - 1).

Every 6 weeks for the first year on study, and then every 12 weeks after year one
Agreement between central view and site review in terms of progression-free survival
Zeitfenster: After the completion of study treatment

The progression status and the progression time will be assessed in agreement. The progression status is a binary measurement and the agreement will be assessed using the Cohen's kappa coefficient. For progression time, will assess the temporal agreement using the method developed by Zeng et al.

After the completion of study treatment
Correlative biomarker research
Zeitfenster: After the completion of study treatment

Correlative biomarker research will be performed on tissue and blood specimens collected within this trial.

After the completion of study treatment

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Joel W Neal, ECOG-ACRIN Cancer Research Group

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

13. Juli 2020

Primärer Abschluss (Geschätzt)

31. März 2027

Studienabschluss (Geschätzt)

31. März 2027

Studienanmeldedaten

Zuerst eingereicht

16. März 2020

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. März 2020

Zuerst gepostet (Tatsächlich)

17. März 2020

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

12. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

11. November 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Ja

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren